查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1493411

实验室产品和服务外包市场规模、份额和趋势分析报告：按产品类型、技术、最终用途、地区和细分市场预测，2024-2030 年

Laboratory Products And Services Outsourcing Market Size, Share & Trends Analysis Report By Type (Products, Services), By Technology (Molecular Diagnostics, Immunoassays), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 250 Pages | 商品交期: 2-10个工作天内

价格

实验室产品和服务外包市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计2030年全球实验室产品和服务外包市场规模将达到671.2亿美元，2024年至2030年复合年增长率为8.21%。

临床试验数量的增加、个人化医疗和新型疗法的采用增加、医疗保健行业研发投资的增加以及医疗设备的技术进步预计将对市场产生积极影响。

截至2023年5月17日，註册临床试验数量已达452,604个，还有64,838个正在积极招募参与企业市场。与 2021 年初报告的超过 365,000 项临床试验相比，这一显着增长代表了临床研究空间的快速扩张。随着越来越多的临床试验开始，对支持研究各个方面（包括样本分析、测试和资料管理）的实验室产品和服务的需求不断增加。这种不断增长的需求为外包公司提供了一个利润丰厚的机会，可以提供专业知识、先进技术和高效的解决方案，以满足临床试验不断变化的要求，从而推动市场成长。

医疗技术在市场中的整合是扩大医疗保健服务领域的潜在成长动力。医疗技术涵盖广泛的设备、软体和服务，在改善诊断、治疗和疾病预防方面发挥着至关重要的作用。利用诊断影像系统（MRI、 电脑断层扫描）、治疗设备（心律调节器、人工关节）和诊断工具（血糖仪）等先进医疗设备，外包公司可以利用专业知识和创新解决方案来满足不断变化的需求。医疗保健业。此外，电子健康记录和远端医疗平台等医疗保健软体和服务可以实现更有效率、更有效的护理服务，进一步推动市场成长轨迹。

个人化医疗和新型治疗方法的日益普及，特别是精准肿瘤学中基于人工智慧的个人化药物和细胞疗法，凸显了对现代法规结构的需求。例如，到 2023 年 1 月，这些框架将确保创新方法安全有效地融入医疗保健系统。这篇演讲强调了临床试验中分散化的好处，强调了透过在更接近患者群体的情况下进行临床试验来简化流程、降低成本和加强患者招募的潜力。此外，以患者为中心的原则已成为个人化医疗发展的基本方面，特别是在精准肿瘤学领域，强调了在医疗决策中优先考虑患者需求、偏好和价值观的重要性。然而，维持分散临床试验的品质和安全性、管理个人化医疗的复杂性以及解决资料隐私和安全问题等挑战包括适应市场内不断变化的个人化医疗格局，这需要监管机构提供创新的解决方案。

此外，医疗设备的技术进步是关键的成长动力，并将在未来几年产生重大影响。例如，使用 3D 列印技术自订植入、矫正器具和烧烫伤患者的皮肤细胞将增强个人化医疗设备的製造并改善患者的治疗效果。此外，使用 3D 列印开发人造器官有可能彻底改变器官移植并减少对捐赠器官的依赖。此外，无氦移动 MRI 系统等创新技术扩大了患者获得诊断扫描的机会，同时解决了环境问题。此外，人工智慧和巨量资料在医疗技术行业的整合，包括在诊断和诊断成像市场的应用，有望带来变革性的好处，将提高业务效率并推动实验室产品和服务外包行业的成长机会。

实验室产品和服务外包市场报告亮点

  • 按产品类型划分，该产品细分市场处于领先地位，2023年将占全球销售份额的62.2%。对先进和专业设备的高需求推动了设备外包科学研究的进步推动了对准确、高效的实验室业务的需求，从而推动了对通用、分析、临床、支援和专业设备的需求不断增加。
  • 从技术角度来看，分子诊断领域预计将在 2023 年占据主导地位，并在预测期内以最快的复合年增长率成长。分子生物学技术的进步和个人化医疗方法的采用将进一步推动对分子诊断服务的需求。
  • 按最终用途划分，製药和生物技术公司预计在预测期内将以 8.4% 的复合年增长率增长最快。由于製药和生物技术公司对研发、外包趋势以及对专业知识的需求的关注，它们正在推动实验室产品和服务外包的成长。
  • 2023 年，北美市场占据主导地位，份额为 38.0%。技术进步、更严格的监管要求以及对专业服务的需求增加等因素促成了这一积极的前景。此外，大型製药企业的存在及其对研发的关注进一步支持了市场扩张。

目录

第一章调查方法和范围

第 2 章执行摘要

第 3 章实验室产品与服务外包市场变数、趋势与范围

  • 市场体系展望
  • 市场动态
  • 技术进步
  • 定价模式分析
  • 临床试验数量分析（2021-2023）
  • 按主要治疗领域分類的临床试验总数（2021-2023）
  • 实验室产品与服务外包市场：分析工具
  • COVID-19 影响分析

第四章实验室产品与服务外包市场：类型估计与趋势分析

  • 细分仪表板
  • 全球实验室产品与服务外包市场波动分析
  • 2018-2030年全球实验室产品与服务外包市场规模及趋势分析（按类型）
  • 产品
  • 服务

第五章实验室产品与服务外包市场：技术评估与趋势分析

  • 细分仪表板
  • 全球实验室产品与服务外包市场波动分析
  • 2018-2030年全球实验室产品及服务外包市场规模及趋势分析（依技术）
  • 免疫学测试
  • 分子诊断
  • 微生物学
  • 临床化学
  • 流式细胞技术
  • 质谱
  • 层析法
  • 其他的

第六章实验室产品和服务外包市场：最终用途估计和趋势分析

  • 细分仪表板
  • 全球实验室产品与服务外包市场波动分析
  • 2018-2030 年全球实验室产品与服务外包市场规模及趋势分析（依最终用途）
  • 製药和生物技术公司
  • 医疗设备公司
  • CRO 和 CDMO
  • 其他的

第七章实验室产品和服务外包市场：按类型、技术和最终用途进行的区域估计和趋势分析

  • 区域市场仪表板
  • 全球区域市场概述
  • 2018-2030年市场规模、预测趋势分析：
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第八章 竞争格局

  • 市场参与企业分类
  • 服务热图分析（企业比较分析）
  • 公司简介
    • Thermo Fisher Scientific
    • Charles River Laboratories
    • Eurofins Scientific
    • Labcorp
    • Quest Diagnostics
    • Parexel International Corporation
    • Agilent Technologies
    • PerkinElmer
    • Bio-Rad Laboratories
    • SGS SA
    • Intertek Group plc
    • WuXi AppTec Co., Ltd.
Product Code: GVR-4-68040-264-5

Laboratory Products And Services Outsourcing Market Growth & Trends:

The global laboratory products and services outsourcing market size is expected to reach USD 67.12 billion by 2030, growing at a CAGR of 8.21% from 2024 to 2030, according to a new report by Grand View Research, Inc. A rising number of clinical trials, increased adoption of the personalized medicine and novel therapeutics, increasing R&D investment in the healthcare industry, technological advancement in the medical equipment are anticipated to positively influence the market.

The surge in registered clinical trials globally, reaching 452,604 as of May 17, 2023, with 64,838 actively recruiting participants, serves as a significant growth driver for the market. This notable increase from over 365,000 trials reported in early 2021 signifies a rapid expansion in the clinical research domain. As more trials are initiated, there is a heightened demand for laboratory products and services to support various aspects of research, including sample analysis, testing, and data management. This escalating need presents lucrative opportunities for outsourcing companies to provide specialized expertise, advanced technologies, and efficient solutions to meet the evolving requirements of clinical trials, thus driving the growth of the market.

The integration of medical technology within the market serves as a potential growth driver, enhancing the landscape of healthcare delivery. Medical technology, encompassing an extensive array of devices, software, and services, plays a pivotal role in improving diagnostics, treatment, and disease prevention. Leveraging advanced medical devices such as imaging systems (MRI, CT scans), therapeutic devices (pacemakers, artificial joints), and diagnostic tools (blood glucose meters), outsourcing companies can provide specialized expertise and innovative solutions to meet the evolving demands of the healthcare industry. Additionally, healthcare software and services, including electronic health records and telemedicine platforms, enable more efficient and effective care delivery, further fueling the growth trajectory of the market.

Increasing adoption of personalized medicine and novel therapeutics, particularly within AI-based personalized drug and cell therapies in precision oncology, highlights the necessity for updated regulatory frameworks. For instance, in January 2023, these frameworks ensure the safe and effective integration of innovative approaches into healthcare systems. Highlighting the benefits of decentralization in clinical trials, the discourse emphasizes its potential to streamline processes, reduce costs, and enhance patient recruitment by conducting trials closer to the patient population. Additionally, the principle of patient centricity emerges as a fundamental aspect of personalized medicine development, emphasizing the importance of prioritizing patients' needs, preferences, and values in healthcare decisions, particularly in precision oncology. However, challenges such as maintaining the quality and safety of decentralized trials, managing the complexities of personalized medicine, and addressing data privacy and security concerns require innovative solutions from regulatory bodies to adapt to the evolving landscape of personalized medicine within the market.

Furthermore, technological advancements in medical equipment present significant growth drivers, poised to make substantial impacts in the upcoming years. For instance, the utilization of 3D printing technology for custom implants, prosthetics, and skin cells for burn victims enhances the production of personalized medical devices, improving patient outcomes. Additionally, the development of artificial organs using 3D printing has the potential to revolutionize organ transplantation, reducing reliance on donor organs. Furthermore, innovations including mobile MRI systems with helium-free operations expand patient access to diagnostic scans while addressing environmental concerns. Moreover, integrating AI and Big Data in the medtech industry, including applications in diagnostics and imaging diagnostics markets, promises transformative benefits, enhancing operational efficiencies and driving growth opportunities in the laboratory products and services outsourcing sector.

Laboratory Products And Services Outsourcing Market Report Highlights:

  • Based on type, the product segment led the market and accounted for 62.2% of global revenue share in 2023. High demand for sophisticated and specialized instruments drives equipment outsourcing. Advancements in scientific research necessitate precise and efficient laboratory operations, fueling the need for general, analytical, clinical, support, and specialty equipment.
  • Based on technology, the molecular diagnostics segment dominated in 2023 and is expected to grow at the fastest CAGR during the forecast period. Advancements in molecular biology techniques and the adoption of personalized medicine approaches further boost the demand for molecular diagnostic services.
  • Based on end-use, the pharmaceutical & biotech companies segment is expected to grow at the fastest CAGR of 8.4% during the forecast period. Pharmaceutical & biotech companies drive growth in lab products and services outsourcing due to R&D focus, outsourcing trends, and demand for specialized expertise.
  • North America dominated the market with a share of 38.0% in 2023. Factors such as technological advancements, stringent regulatory requirements, and the increasing demand for specialized services contribute to this positive outlook. Additionally, the presence of leading pharmaceutical and biotechnology companies and a strong emphasis on research and development further propels market expansion.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Regional Scope
    • 1.1.2. Estimates and Forecast Timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
    • 1.3.5. Details of Primary Research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Validation
    • 1.5.1. Region Wise Market: Base Estimates
    • 1.5.2. Global Market: CAGR Calculation
  • 1.6. Model Details
    • 1.6.1. Commodity Flow Analysis (Model 1)
    • 1.6.2. Value-Chain-Based Sizing & Forecasting (Model 2)
    • 1.6.3. QFD Model Sizing & Forecasting (Model 3)
    • 1.6.4. Bottom-Up Approach (Model 4)
  • 1.7. Market Definitions
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. Objectives
    • 1.10.1. Objective - 1:
    • 1.10.2. Objective - 2:
    • 1.10.3. Objective - 3:
    • 1.10.4. Objective - 4:

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Laboratory Products and Services Outsourcing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing Number of Clinical Trials
      • 3.2.1.2. Increasing Adoption of the Personalized Medicine and Novel Therapeutics
      • 3.2.1.3. Rising R&D Investment in the Healthcare Industry
      • 3.2.1.4. Technological Advancement in the Medical Equipment
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Regulatory Challenges
      • 3.2.2.2. Managing Relationships
  • 3.3. Technological Advancements
  • 3.4. Pricing Model Analysis
  • 3.5. Clinical Trial Volume Analysis (2021 - 2023)
    • 3.5.1. Total Number of Clinical Trials, by Region (2021 - 2023)
    • 3.5.2. Total Number of Clinical Trials, by Phase (2021 - 2023)
    • 3.5.3. Total Number of Clinical Trials, by Study Design (2021 - 2023)
  • 3.6. Total Number of Clinical Trials, by Key Therapeutic Area (2021 - 2023)
  • 3.7. Laboratory Products And Services Outsourcing Market: Analysis Tools
    • 3.7.1. Porter's Five Forces Analysis
    • 3.7.2. PESTEL Analysis
  • 3.8. COVID-19 Impact Analysis

Chapter 4. Laboratory Products and Services Outsourcing Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Laboratory Products and Services Outsourcing Market Movement Analysis
  • 4.3. Global Laboratory Products and Services Outsourcing Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Products
    • 4.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 4.4.2. Equipment
      • 4.4.2.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.4.2.2. General
      • 4.4.2.2.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.4.2.3. Analytical
      • 4.4.2.3.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.4.2.4. Clinical
      • 4.4.2.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.4.2.5. Support
      • 4.4.2.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.4.2.6. Specialty
      • 4.4.2.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 4.4.3. Disposables
      • 4.4.3.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 4.5.2. Pharmaceutical
      • 4.5.2.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.2.2. Bioanalytical Testing
      • 4.5.2.2.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.2.2.2. ADME
      • 4.5.2.2.2.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.2.2.3. PK
      • 4.5.2.2.3.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.2.2.4. PD
      • 4.5.2.2.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.2.2.5. Bioavailability
      • 4.5.2.2.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.2.2.6. Bioequivalence
      • 4.5.2.2.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.2.2.7. Others
      • 4.5.2.2.7.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.2.3. Method Development & Validation
      • 4.5.2.3.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.2.3.2. Extractable & Leachable
      • 4.5.2.3.2.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.2.3.3. Impurity Method
      • 4.5.2.3.3.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.2.3.4. Technical Consulting
      • 4.5.2.3.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.2.3.5. Others
      • 4.5.2.3.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.2.4. Stability Testing
      • 4.5.2.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.2.4.2. Drug Substance
      • 4.5.2.4.2.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.2.4.3. Stability Indicating Method Validation
      • 4.5.2.4.3.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.2.4.4. Accelerated Stability Testing
      • 4.5.2.4.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.2.4.5. Photostability Testing
      • 4.5.2.4.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.2.4.6. Others
      • 4.5.2.4.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.2.5. Others
      • 4.5.2.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 4.5.3. Medical Device
      • 4.5.3.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.3.1.1. Biocompatibility Tests
      • 4.5.3.1.1.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.3.1.2. Chemistry Test
      • 4.5.3.1.2.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.3.1.3. Microbiology & Sterility Testing
      • 4.5.3.1.3.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.3.1.4. Others
      • 4.5.3.1.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)

Chapter 5. Laboratory Products and Services Outsourcing Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Laboratory Products and Services Outsourcing Market Movement Analysis
  • 5.3. Global Laboratory Products and Services Outsourcing Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
  • 5.4. Immunoassays
    • 5.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.5. Molecular Diagnostics
    • 5.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.6. Microbiology
    • 5.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.7. Clinical Chemistry
    • 5.7.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.8. Flow Cytometry
    • 5.8.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.9. Mass Spectroscopy
    • 5.9.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.10. Chromatography
    • 5.10.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.11. Others
    • 5.11.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)

Chapter 6. Laboratory Products and Services Outsourcing Market: End-use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Laboratory Products and Services Outsourcing Market Movement Analysis
  • 6.3. Global Laboratory Products and Services Outsourcing Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
  • 6.4. Pharmaceutical & Biotech Companies
    • 6.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 6.5. Medical Device Companies
    • 6.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 6.6. CRO & CDMO
    • 6.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)

Chapter 7. Laboratory Products and Services Outsourcing Market: Regional Estimates & Trend Analysis by Type, Technology & End-use

  • 7.1. Regional Market Dashboard
  • 7.2. Global Regional Market Snapshot
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Scenario
      • 7.4.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Scenario
      • 7.4.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Scenario
      • 7.5.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Scenario
      • 7.5.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Scenario
      • 7.5.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Scenario
      • 7.5.5.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Scenario
      • 7.5.6.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Scenario
      • 7.5.7.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Scenario
      • 7.5.8.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Scenario
      • 7.5.9.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Scenario
      • 7.6.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.6.3. Japan
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Scenario
      • 7.6.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Scenario
      • 7.6.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Scenario
      • 7.6.5.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Scenario
      • 7.6.6.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Scenario
      • 7.6.7.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Scenario
      • 7.7.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.7.3. Mexico
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Scenario
      • 7.7.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.7.4. Argentina
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Scenario
      • 7.7.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Scenario
      • 7.8.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Scenario
      • 7.8.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Scenario
      • 7.8.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Scenario
      • 7.8.5.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Service Heat Map Analysis (a comparative analysis of the players together)
  • 8.3. Company Profiles
    • 8.3.1. Thermo Fisher Scientific
      • 8.3.1.1. Company Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Product/Service Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Charles River Laboratories
      • 8.3.2.1. Company Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Product/Service Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Eurofins Scientific
      • 8.3.3.1. Company Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Product/Service Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Labcorp
      • 8.3.4.1. Company Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Product/Service Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Quest Diagnostics
      • 8.3.5.1. Company Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Product/Service Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Parexel International Corporation
      • 8.3.6.1. Company Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Product/Service Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Agilent Technologies
      • 8.3.7.1. Company Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Product/Service Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. PerkinElmer
      • 8.3.8.1. Company Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Product/Service Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Bio-Rad Laboratories
      • 8.3.9.1. Company Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Product/Service Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. SGS SA
      • 8.3.10.1. Company Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Product/Service Benchmarking
      • 8.3.10.4. Strategic Initiatives
    • 8.3.11. Intertek Group plc
      • 8.3.11.1. Company Overview
      • 8.3.11.2. Financial Performance
      • 8.3.11.3. Product/Service Benchmarking
      • 8.3.11.4. Strategic Initiatives
    • 8.3.12. WuXi AppTec Co., Ltd.
      • 8.3.12.1. Company Overview
      • 8.3.12.2. Financial Performance
      • 8.3.12.3. Product/Service Benchmarking
      • 8.3.12.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 4 Global Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 5 Global Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 6 Global Laboratory Products and Services Outsourcing, by Region, 2018 - 2030 (USD Million)
  • Table 7 North America Laboratory Products and Services Outsourcing, by Country, 2018 - 2030 (USD Million)
  • Table 8 North America Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 9 North America Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 10 North America Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 11 U.S. Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 12 U.S. Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 13 U.S. Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 14 Canada Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 15 Canada Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 16 Canada Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 17 Europe Laboratory Products and Services Outsourcing, by Country, 2018 - 2030 (USD Million)
  • Table 18 Europe Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 19 Europe Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 20 Europe Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 21 Germany Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 22 Germany Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 23 Germany Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 24 UK Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 25 UK Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 26 UK Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 27 France Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 28 France Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 29 France Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 30 Italy Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 31 Italy Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 32 Italy Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 33 Spain Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 34 Spain Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 35 Spain Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 36 Denmark Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 37 Denmark Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 38 Denmark Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 39 Sweden Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 40 Sweden Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 41 Sweden Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 42 Norway Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 43 Norway Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 44 Norway Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Laboratory Products and Services Outsourcing, by Country, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 49 China Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 50 China Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 51 China Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 52 Japan Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 53 Japan Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 54 Japan Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 55 India Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 56 India Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 57 India Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 58 South Korea Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 59 South Korea Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 60 South Korea Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 61 Australia Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 62 Australia Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 63 Australia Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 64 Thailand Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 65 Thailand Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 66 Thailand Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 67 Latin America Laboratory Products and Services Outsourcing, by Country, 2018 - 2030 (USD Million)
  • Table 68 Latin America Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 69 Latin America Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 70 Latin America Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 71 Brazil Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 72 Brazil Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 73 Brazil Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 74 Mexico Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 75 Mexico Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 76 Mexico Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 77 Argentina Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 78 Argentina Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 79 Argentina Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Laboratory Products and Services Outsourcing, by Country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 84 South Africa Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 85 South Africa Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 86 South Africa Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 90 UAE Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 91 UAE Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 92 UAE Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Laboratory Products and Services Outsourcing, Market Segmentation
  • Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Regional Marketplace: Key Takeaways
  • Fig. 12 Global Laboratory Products and Services Outsourcing, for Product, 2018 - 2030 (USD Million)
  • Fig. 13 Global Laboratory Products and Services Outsourcing, for Equipment, 2018 - 2030 (USD Million)
  • Fig. 14 Global Laboratory Products and Services Outsourcing, for Equipment, 2018 - 2030 (USD Million)
  • Fig. 15 Global Laboratory Products and Services Outsourcing, for General, 2018 - 2030 (USD Million)
  • Fig. 16 Global Laboratory Products and Services Outsourcing, for Analytical, 2018 - 2030 (USD Million)
  • Fig. 17 Global Laboratory Products and Services Outsourcing, for Clinical, 2018 - 2030 (USD Million)
  • Fig. 18 Global Laboratory Products and Services Outsourcing, for Support, 2018 - 2030 (USD Million)
  • Fig. 19 Global Laboratory Products and Services Outsourcing, for Specialty, 2018 - 2030 (USD Million)
  • Fig. 20 Global Laboratory Products and Services Outsourcing, for Disposables, 2018 - 2030 (USD Million)
  • Fig. 21 Global Laboratory Products and Services Outsourcing, for Others, 2018 - 2030 (USD Million)
  • Fig. 22 Global Laboratory Products and Services Outsourcing, for Services, 2018 - 2030 (USD Million)
  • Fig. 23 Global Laboratory Products and Services Outsourcing, for Pharmaceutical, 2018 - 2030 (USD Million)
  • Fig. 24 Global Laboratory Products and Services Outsourcing, for Bioanalytical Testing, 2018 - 2030 (USD Million)
  • Fig. 25 Global Laboratory Products and Services Outsourcing, for ADME, 2018 - 2030 (USD Million)
  • Fig. 26 Global Laboratory Products and Services Outsourcing, for PK, 2018 - 2030 (USD Million)
  • Fig. 27 Global Laboratory Products and Services Outsourcing, for PD, 2018 - 2030 (USD Million)
  • Fig. 28 Global Laboratory Products and Services Outsourcing, for Bioavailability, 2018 - 2030 (USD Million)
  • Fig. 29 Global Laboratory Products and Services Outsourcing, for Bioequivalence, 2018 - 2030 (USD Million)
  • Fig. 30 Global Laboratory Products and Services Outsourcing, for Others, 2018 - 2030 (USD Million)
  • Fig. 31 Global Laboratory Products and Services Outsourcing, for Method Development and Validation, 2018 - 2030 (USD Million)
  • Fig. 32 Global Laboratory Products and Services Outsourcing, for Extractable and Leachable, 2018 - 2030 (USD Million)
  • Fig. 33 Global Laboratory Products and Services Outsourcing, for Impurity Method, 2018 - 2030 (USD Million)
  • Fig. 34 Global Laboratory Products and Services Outsourcing, for Technical Consulting, 2018 - 2030 (USD Million)
  • Fig. 35 Global Laboratory Products and Services Outsourcing, for Others, 2018 - 2030 (USD Million)
  • Fig. 36 Global Laboratory Products and Services Outsourcing, for Stability Testing, 2018 - 2030 (USD Million)
  • Fig. 37 Global Laboratory Products and Services Outsourcing, for Drug Substance, 2018 - 2030 (USD Million)
  • Fig. 38 Global Laboratory Products and Services Outsourcing, for Stability Indicating Method Validation, 2018 - 2030 (USD Million)
  • Fig. 39 Global Laboratory Products and Services Outsourcing, for Accelerated Stability Testing, 2018 - 2030 (USD Million)
  • Fig. 40 Global Laboratory Products and Services Outsourcing, for Photostability Testing, 2018 - 2030 (USD Million)
  • Fig. 41 Global Laboratory Products and Services Outsourcing, for Others, 2018 - 2030 (USD Million)
  • Fig. 42 Global Laboratory Products and Services Outsourcing, for Medical Device, 2018 - 2030 (USD Million)
  • Fig. 43 Global Laboratory Products and Services Outsourcing, for Biocompatibility Tests, 2018 - 2030 (USD Million)
  • Fig. 44 Global Laboratory Products and Services Outsourcing, for Chemistry Test, 2018 - 2030 (USD Million)
  • Fig. 45 Global Laboratory Products and Services Outsourcing, for Microbiology & Sterility Testing, 2018 - 2030 (USD Million)
  • Fig. 46 Global Laboratory Products and Services Outsourcing, for Others, 2018 - 2030 (USD Million)
  • Fig. 47 Global Laboratory Products and Services Outsourcing, for Immunoassays, 2018 - 2030 (USD Million)
  • Fig. 48 Global Laboratory Products and Services Outsourcing, for Molecular Diagnostics, 2018 - 2030 (USD Million)
  • Fig. 49 Global Laboratory Products and Services Outsourcing, for Microbiology, 2018 - 2030 (USD Million)
  • Fig. 50 Global Laboratory Products and Services Outsourcing, for Clinical Chemistry, 2018 - 2030 (USD Million)
  • Fig. 51 Global Laboratory Products and Services Outsourcing, for Flow Cytometry, 2018 - 2030 (USD Million)
  • Fig. 52 Global Laboratory Products and Services Outsourcing, for Chromatography, 2018 - 2030 (USD Million)
  • Fig. 53 Global Laboratory Products and Services Outsourcing, for Mass Spectroscopy, 2018 - 2030 (USD Million)
  • Fig. 54 Global Laboratory Products and Services Outsourcing, for Others, 2018 - 2030 (USD Million)
  • Fig. 55 Global Laboratory Products and Services Outsourcing, for Medical Device Companies, 2018 - 2030 (USD Million)
  • Fig. 56 Global Laboratory Products and Services Outsourcing, for Pharmaceutical & Biotech Companies, 2018 - 2030 (USD Million)
  • Fig. 57 Global Laboratory Products and Services Outsourcing, for CRO & CDMO, 2018 - 2030 (USD Million)
  • Fig. 58 Global Laboratory Products and Services Outsourcing, for Others, 2018 - 2030 (USD Million)
  • Fig. 59 Regional Outlook, 2023 & 2030
  • Fig. 60 North America Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 U.S. Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Canada Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Europe Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Germany Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 UK Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 France Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Italy Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Spain Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Denmark Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Sweden Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Norway Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Asia Pacific Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Japan Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 China Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 India Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Australia Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 South Korea Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Thailand Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Latin America Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Brazil Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Mexico Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Argentina Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Middle East and Africa Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 South Africa Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Saudi Arabia Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 UAE Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Kuwait Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)